Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. 1984

S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg

Norfloxacin, an orally administered quinoline carboxylic acid that is structurally related to nalidixic acid, has been shown to be highly active in vitro against penicillinase-producing Neisseria gonorrhoeae. Ninety-two men with culture-proved gonococcal urethritis, 46 per cent with penicillinase-producing N. gonorrhoeae, and 27 per cent with non-penicillinase-producing N. gonorrhoeae that was resistant to penicillin were given either 1200 mg of norfloxacin divided into two equal oral doses four hours apart (59 patients) or 2 g of spectinomycin intramuscularly (33 patients). All patients in both treatment groups were cured. No adverse reactions were reported in either group. We conclude that a two-dose, single-day regimen of orally administered norfloxacin is effective therapy for uncomplicated urethritis caused by penicillin-resistant strains of N. gonorrhoeae.

UI MeSH Term Description Entries
D008297 Male Males
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000198 Spectinomycin An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA. Actinospectacin,Adspec,Ferkel Spectam,Kempi,Prospec,Salmosan-T,Spectam,Spectinomycin Dihydrochloride, Anhydrous,Spectinomycin Dihydrochloride, Pentahydrate,Spectinomycin Hydrochloride,Stanilo,Trobicin,Salmosan T,Spectam, Ferkel

Related Publications

S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
September 1990, Lancet (London, England),
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
June 1978, Ceskoslovenska dermatologie,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
August 1991, Genitourinary medicine,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
June 1986, The Medical journal of Australia,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
January 2001, Indian journal of medical microbiology,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
November 1987, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
November 1981, Journal of the South Carolina Medical Association (1975),
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
July 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
December 2001, Antimicrobial agents and chemotherapy,
S R Crider, and S D Colby, and L K Miller, and W O Harrison, and S B Kerbs, and S W Berg
March 1988, Nature,
Copied contents to your clipboard!